Drug Topics

How GLP-1s are reshaping cultural views on body image

This leg condition that’s overlooked in women can raise heart attack, stroke risk

CIDRAP Op-Ed: HHS is asking what to call vaccine recommendations. You have 4 days to weigh in.

Large genetic study links GLP-1 receptor activation to improved mental well-being

Exclusive / Cassidy rips RFK Jr. on vaccines: ‘This is not making America healthy again’

I’m a dementia expert. This is what HRT really does to women’s brains

The weight I lost with GLP-1s came back ‘with taxes’

Your guide to fall 2026 vaccines

FDA approves new use of popular diabetes drug

Shingles vaccine linked to 24% lower dementia risk

Trump administration quietly signals possible changes coming to childhood vaccine schedule

Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide

Eli Lilly is planning a Q1 2027 FDA application for retatrutide following new data on weight loss and A1C improvements.

24 GLP-1 Users Reveal The Good, The Bad, And The Shocking Side Effects

GLP-1 weight-loss medications are seeing a massive surge in adoption, sparking debates over side effects and social disclosure.

She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

The pitfalls of using social media and AI for health decisions, according to a doctor

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

West Nile is spreading faster than it has in 20 years. Here’s how to keep yourself safe

10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

‘World’s most contagious disease’ on track for highest US cases in 35 years

Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America

Eli Lilly's CEO outlines the transformative potential of GLP-1s as new oral weight-loss medications enter development.